Rankings
▼
Calendar
CGEN FY 2020 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena
CGEN
Compugen Ltd.
$215M
FY 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
Gross Profit
$2M
97.0% margin
Operating Income
-$31M
-1574.8% margin
Net Income
-$30M
-1484.9% margin
EPS (Diluted)
$-0.37
Cash Flow
Operating Cash Flow
-$28M
Free Cash Flow
-$28M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$138M
Total Liabilities
$19M
Stockholders' Equity
$120M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$0
—
Gross Profit
$2M
-$989,000
+296.2%
Operating Income
-$31M
-$29M
-9.1%
Net Income
-$30M
-$27M
-8.6%
← Q4 2019
All Quarters
Q1 2020 →